Education

Ph.D. in Biochemistry, Free University (FU) of Berlin, Germany, 2013

Current position

Postdoctoral scientist and Deputy group leader in the group of Prof. Dr. W-H. Zimmermann/Dr. L. Zelarayán, Institute of Pharmacology, University Medical Center Göttingen (UMG), Göttingen, Germany

Publications

1. Zafiriou, M. P., Noack, C., Unsold, B., Didie, M., Pavlova, E., Fischer, H. J., Reichardt, H. M., Bergmann, M. W., El-Armouche, A., Zimmermann, W. H. and Zelarayan, L. C. (2014). Erythropoietin responsive cardiomyogenic cells contribute to heart repair post myocardial infarction. Stem Cells 32(9): 2480-2491.
   
2. Renger, A., Zafiriou, M. P., Noack, C., Pavlova, E., Becker, A., Sharkova, K., Bergmann, M. W., El-Armouche, A., Zimmermann, W. H. and Zelarayan, L. C. (2013). The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating beta-catenin-dependent transcription. Stem Cells 31(5): 928-940.
   
3. Noack, C., Zafiriou, M. P., Schaeffer, H. J., Renger, A., Pavlova, E., Dietz, R., Zimmermann, W. H., Bergmann, M. W. and Zelarayan, L. C. (2012). Krueppel-like factor 15 regulates Wnt/beta-catenin transcription and controls cardiac progenitor cell fate in the postnatal heart. EMBO Mol Med 4(9): 992-1007.
   
4. Zafiriou, M. P., Zelarayan, L. C., Noack, C., Renger, A., Nigam, S. and Siafaka-Kapadai, A. (2011). Hepoxilin A(3) protects beta-cells from apoptosis in contrast to its precursor, 12-hydroperoxyeicosatetraenoic acid. Biochim Biophys Acta 1811(6): 361-369.
   
5. Christian, F., Szaszak, M., Friedl, S., Drewianka, S., Lorenz, D., Goncalves, A., Furkert, J., Vargas, C., Schmieder, P., Gotz, F., Zuhlke, K., Moutty, M., Gottert, H., Joshi, M., Reif, B., Haase, H., Morano, I., Grossmann, S., Klukovits, A., Verli, J., Gaspar, R., Noack, C., Bergmann, M., Kass, R., Hampel, K., Kashin, D., Genieser, H. G., Herberg, F. W., Willoughby, D., Cooper, D. M., Baillie, G. S., Houslay, M. D., von Kries, J. P., Zimmermann, B., Rosenthal, W. and Klussmann, E. (2011). Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. J Biol Chem 286(11): 9079-9096.
   
6. Zelarayan, L. C., Noack, C., Zafiriou, M. P., Renger, A. and Bergmann, M. W. (2010). Wnt signaling molecules in left ventricular remodeling: focus on dishevelled 1. Hypertension 55(4): 852-854.
   
7. Zelarayan, L., Renger, A., Noack, C., Zafiriou, M. P., Gehrke, C., van der Nagel, R., Dietz, R., de Windt, L. and Bergmann, M. W. (2009). NF-kappaB activation is required for adaptive cardiac hypertrophy. Cardiovasc Res 84(3): 416-424.
   
8. Zelarayan, L. C., Noack, C., Sekkali, B., Kmecova, J., Gehrke, C., Renger, A., Zafiriou, M. P., van der Nagel, R., Dietz, R., de Windt, L. J., Balligand, J. L. and Bergmann, M. W. (2008). Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci U S A 105(50): 19762-19767.
   
9. Baurand, A., Zelarayan, L., Betney, R., Gehrke, C., Dunger, S., Noack, C., Busjahn, A., Huelsken, J., Taketo, M. M., Birchmeier, W., Dietz, R. and Bergmann, M. W. (2007). Beta-catenin downregulation is required for adaptive cardiac remodeling. Circ Res 100(9): 1353-1362.